Citation Impact
Citing Papers
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
The Immunology of Fibrosis
2013
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease
2001
Symptoms of gastro‐oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population
2003
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
2009
IL-22-Dependent Attenuation of T Cell-Dependent (ConA) Hepatitis in Herpes Virus Entry Mediator Deficiency
2009
Ebselen Protects Mice Against T Cell-Dependent, TNF-Mediated Apoptotic Liver Injury
1998
Onset and disappearance of reflux symptoms in a Chinese population: a 1‐year follow‐up study
2004
Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options
2000
Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome
1996
Relationship of Interleukin-10 Plasma Levels to Severity of Injury and Clinical Outcome in Injured Patients
1997
Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia–Pacific region: The FAST survey
2004
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
2008 StandoutNature
Acute kidney injury
2012 Standout
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*
2005
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes
2004
Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis
2003
Evidence for Superantigen Involvement in Severe Group A Streptococcal Tissue Infections
2001
Hepatitis C Virus Infection
2001 Standout
Interleukin‐10: Potential Benefits and Possible Risks in Clinical Infectious Diseases
1998
Suppressive Effects of Interleukin‐10 on Human Mononuclear Phagocyte Function againstCandida albicansandStaphylococcus aureus
1998
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis
1998
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
1999
High Levels Of Interleukin-10 During The Initial Phase Of Fulminant Meningococcal Septic Shock
1995
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages
2001
Downregulation of Cytokine-induced Neutrophil Chemoattractant and Prolongation of Rat Liver Allograft Survival by Interleukin-10
1998
Hypoxia and Inflammation
2011 Standout
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.
1996
Epidemiology of sepsis: An update
2001
Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock
1995
Liver: An organ with predominant innate immunity
2007
Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis.
1995
Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
2000
Interleukin–10 Controls Neutrophilic Infiltration, Hepatocyte Proliferation, and Liver Fibrosis Induced by Carbon Tetrachloride in Mice
1998
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease
2003
IL-10 immunosuppression in transplantation
1995
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22
2010
Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia
2000
Interleukin 10 Inhibits the Release of CC Chemokines during Human Endotoxemia
2000
Severe Sepsis and Septic Shock
2013 Standout
Acute Pancreatitis
2016 Standout
Infections and the Inflammatory Response in Acute Respiratory Distress Syndrome
1997
Interleukin-10 Is Associated with the Development of Sepsis in Trauma Patients
1996
Interleukin-10 and the Monocyte/Macrophage-Induced Inflammatory Response in Septic Shock
1995
Recombinant Human Interleukin‐10 Fails to Alter Proinflammatory Cytokine Production or Physiologic Changes Associated with the Jarisch‐Herxheimer Reaction
2000
Increased Serum Concentrations of Interleukin-10 in Patients with Hepatosplenic Candidiasis
1998
Epidemiology of gastro-oesophageal reflux disease: a systematic review
2005 Standout
Global cancer statistics
2011 Standout
Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB
1999
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Prevalence, clinical spectrum and health care utilization of gastro‐oesophageal reflux disease in a Chinese population: a population‐based study
2003
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock*
2007
Spermine increases arginase activity in the liver after carbon tetrachloride-induced hepatic injury in Long-Evans rats
2005
The development of allergic inflammation
2008 StandoutNature
Inflammatory Mediators, Cytokines, and Adhesion Molecules in Pulmonary Inflammation and Injury
1996
Has the mortality of septic shock changed with time?
1998
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation
2004
Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care Unit
2005
Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis
2011
Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis
1995
Sepsis: A New Hypothesis for Pathogenesis of the Disease Process
1997
Anti-Inflammatory Cytokines
2000
Sir Isaac Newton, sepsis, SIRS, and CARS
1996 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Serum levels of cytokines in chronic liver diseases
1992
Gut flora in health and disease
2003 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Ventilator-Induced Lung Injury
2013 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Interleukin-10 Therapy—Review of a New Approach
2003
Interieukin-10 Impairs Host Defense in Murine Pneumococcal Pneumonia
1996
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
2004
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Points of control in inflammation
2002 StandoutNature
Antiinflammatory Cytokine Responses during Clinical Sepsis and Experimental Endotoxemia: Sequential Measurements of Plasma Soluble Interleukin (IL)-1 Receptor Type II, IL-10, and IL-13
1997
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
The inflammatory reflex
2002 StandoutNature
Interleukin-6 and its receptors: A highly regulated and dynamic system
2014
Early lactate clearance is associated with improved outcome in severe sepsis and septic shock*
2004 Standout
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Shaping of monocyte and macrophage function by adenosine receptors
2006
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
2014 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Increased Th17 cells contribute to disease progression in patients with HBV‐associated liver cirrhosis
2012
The immunopathogenesis of sepsis
2002 StandoutNature
Genetic Risk Factors for Pancreatic Disorders
2013
Antifungal type 1 responses are upregulated in IL-10-deficient mice
1999
Interleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung Transplantation
2002
Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis
1999
Impaired antigen presentation by human monocytes during endotoxin tolerance
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Endogenous IL-10 protects mice from death during septic peritonitis
1995
The role of the graft in establishing tolerance
2002
Time Trends of Gastroesophageal Reflux Disease: A Systematic Review
2006
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.
1994
Interleukin 10 reduces mortality from severe peritonitis in mice
1995
Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes.
1996
Concanavalin A-induced Hepatitis in Mice is Prevented by Interleukin (IL)-10 and Exacerbated by Endogenous IL-10 Deficiency
1999
Spermidine in health and disease
2018 StandoutScience
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis
1998
Role of Interleukin-10 in a Murine Model of Dextran Sulfate Sodium-Induced Colitis
1998
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
A2A adenosine receptors and C/EBPβ are crucially required for IL-10 production by macrophages exposed to Escherichia coli
2007
IL-17A Enhances the Expression of Profibrotic Genes through Upregulation of the TGF-β Receptor on Hepatic Stellate Cells in a JNK-Dependent Manner
2014
Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
2006
Interleukin-10 Counterregulates Proinflammatory Cytokine-Induced Inhibition of Neutrophil Apoptosis During Severe Sepsis
1997
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
High levels of interleukin 10 in serum are associated with fatality in meningococcal disease
1995
Pathogenesis of DIC in Sepsis
1999
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts
1999
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Jacques Devière being referenced
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis
1995
Serum Cytokine Levels in Human Septic Shock
1993
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease
2011
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
2006
Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice
1997
NoMycobacterium paratuberculosis found in crohn's disease using the polymerase chain reaction
1996
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
2006
Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice
1996
Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources
2002
Critical role of interleukin 5 and eosinophils in concanavalin A–induced hepatitis in mice
2002
Interleukin-10 production during septicaemia
1994
Systemic Release of Interleukin–10 During Orthotopic Liver Transplantation
1994
Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury
1997
CCR5 Deficiency Exacerbates T-Cell–Mediated Hepatitis in Mice *
2005
The interleukin-17 pathway is involved in human alcoholic liver disease # †
2008
IgA triggers tumor necrosis factor α secretion by monocytes: A study in normal subjects and patients with alcoholic cirrhosis
1991
Modulation of liver injury by interleukin-10.
2003
Adenosine enhances IL-10 secretion by human monocytes.
1996
An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease
2009